| Rachel Miller, CCC-SLP | |
|
555 E Cheves St, Florence, SC 29506-2617 | |
| (843) 777-2250 | |
| (843) 777-2051 |
| Full Name | Rachel Miller |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | 555 E Cheves St, Florence, South Carolina |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1073710604 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | 3108 (South Carolina) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Rachel Miller, CCC-SLP 555 E Cheves St, Florence, SC 29506-2617 Ph: (843) 777-2250 | Rachel Miller, CCC-SLP 555 E Cheves St, Florence, SC 29506-2617 Ph: (843) 777-2250 |
News Archive
Delcath Systems, Inc., a specialty pharmaceutical and medical device company focused on oncology with an emphasis on the treatment of primary and metastatic liver cancers, announced today that the U.S. Food and Drug Administration Office of Orphan Products Development has granted Orphan Drug Designation for melphalan for the treatment of cholangiocarcinoma.
With millions of COVID-19 cases reported across the globe, people are turning to antibody tests to find out whether they have been exposed to the coronavirus that causes the disease. But what are antibodies? Why are they important? If we have them, are we immune to COVID-19? And if not, why not?
QIAGEN N.V. and DiaSorin today announced the introduction of an automated, CE-marked workflow for QIAGEN's QuantiFERON-TB Gold Plus Blood Collection Tubes (QFT-Plus BCT) and a novel DiaSorin LIAISON Test on widely used immunodiagnostic instruments from DiaSorin.
Individuals with subclinical hypothyroidism - a mildly underactive thyroid only detectable by a blood test - are twice as likely to develop heart failure, compared to those with normal thyroid levels, according to a new study presented on Thursday, Oct. 4, at the 78th Annual Meeting of the American Thyroid Association (ATA) in New York.
Garnet BioTherapeutics, Inc., a regenerative medicine company focused on developing cell based therapies, today announced that the first patient has been treated in a Phase 2 multicenter, double-blind, placebo-controlled study of its lead product candidate GBT009 at Unity Hospital in Rochester, New York. GBT009 gives off a variety of pro-regenerative growth factors and cytokines which help repair damaged tissue and reduce inflammation, ultimately augmenting the body's ability to heal itself.
› Verified 9 days ago
Tara Mckenzie, MSP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 555 E Cheves St, Florence, SC 29506 Phone: 843-777-2250 Fax: 843-777-2051 | |
Valerie Schmidt, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2100 Twin Church Rd, Florence, SC 29501 Phone: 843-664-0700 | |
Mr. Corey Artedius Bess, MA, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2330 Julie Ann Dr, Florence, SC 29505 Phone: 843-665-1870 | |
Haley Wightman, MCD,CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 555 E Cheves St, Rehab Services, Florence, SC 29506 Phone: 843-777-2250 Fax: 843-777-2051 | |
Amanda Wyse, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 555 E Cheves St, Florence, SC 29506 Phone: 843-777-2250 Fax: 843-777-2051 | |
Jan Parish, MED,CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 555 E Cheves St, Rehab Services, Florence, SC 29506 Phone: 843-777-2250 Fax: 843-777-2051 | |
Lisa Alves, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 344 Bristol St, Florence, SC 29501 Phone: 843-673-9687 |